Coralville, IA (October 4, 2019) — VIDA Diagnostics, Inc. (“VIDA”), the leader in AI-powered lung imaging analysis, today announced the appointment of Erkan Akyuz as to help guide the company’s growth initiatives with differentiated healthcare IT leadership and market expertise.

“I am energized to join VIDA’s Board of Directors,” stated Erkan Akyuz, President and CEO at Rhapsody and Corepoint Health. “VIDA has the potential to significantly expand its presence in the healthcare AI market and bring precise, personalized information to care providers. I’m looking forward to working with VIDA’s exceptional team as they continue their growth trajectory.”

“I am thrilled to welcome Mr. Akyuz to VIDA’s Board of Directors,” said Susan A. Wood, PhD, President and CEO of VIDA. “His expertise in leading healthcare IT organizations and market understanding is a perfect fit with our shared vision of expanding access to our innovative, AI- powered clinical solution that improves the lives of pulmonary patients and populations."